19 Nov 2009 16:23
PLETHORA SOLUTIONS HOLDINGS PLC
("Plethora" or the "Company")
Directors' dealings
As announced on 18 November 2009, the Directors intend to participate in the Fundraising through the subscription for 1,950,000 new ordinary shares at the placing price of 10p each. In aggregate they will invest £195,000 in the placing, being 12.5% of the Fundraising. The Directors' interests in the Company before and following completion of the Fundraising is set out in the table below.
| Number of Ordinary Shares currently held | Number of Ordinary Shares subscribed for | Shares held on Admission of New Ordinary Shares | Options currently held* | Percentage of fully diluted issued share capital | |
| Director | |||||
| William Robinson | - | 1,000,000 | 1,000,000 | - | 1.6% |
| Dr. Steven Powell | 4,100 | 500,000 | 504,100 | 1,334,951 | 2.9% |
| Dr. Mike Wyllie | 486,494 | 200,000 | 686,494 | 724,491 | 2.3% |
| Ronald Openshaw | - | 250,000 | 250,000 | - | 0.4% |
*All options held are exercisable at between 59p and 202p
Following the Fundraising, the total enlarged issued share capital of the Company will be 41,965,800 and no ordinary shares will be held in treasury. Therefore, following the Placing, the total number of voting rights in the Company will be 41,965,800. The above figure may be used by shareholders in determining whether they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.
Enquiries:
Plethora Solutions
Steven Powell Tel : +44(0) 20 3077 5400
FinnCap
Geoff Nash/Marc Young Tel : +44(0) 20 7600 1658
Hansard Group
Adam Reynolds/John Bick Tel: +44(0) 20 7245 1100
About Plethora:
Plethora is focused on the development and marketing of products for the treatment of urological disorders. The Company has products in clinical development for the treatment of overactive bladder, stress urinary incontinence, interstitial cystitis, gynaecological pain, erectile dysfunction and premature ejaculation. The Company is headquartered in the UK and is listed on the London Stock Exchange (AIM:PLE)
Further information is available at www.plethorasolutions.co.uk